reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 1603.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 2 - Human Whole Blood and Human Whole Blood Derivatives|Section 1603.5.

1603.5.  (a)  Notwithstanding any other provision of law, every person engaged in the production of blood shall, if the product is intended for transfusion, label each container of blood which the person produces with a label, upon which the following designations shall be printed in letters the size of which shall be no less prominent than the proper name of the product. (1)  If the person giving the blood received no payment for the blood, the designation shall be “volunteer donor.” (2)  If the person giving the blood received payment for the blood, the designation shall be “paid donor.” (b)  As used in this section: (1)  “Blood” means human whole blood or components of human blood, including plasma, which are prepared from human whole blood by physical, rather than chemical processes, but does not include blood derivatives manufactured or processed by industrial use. (2)  “Industrial use” means a use of blood in which the blood is modified by physical or chemical means to produce derivatives for therapeutic or pharmaceutic biologics, laboratory reagents, or in vitro diagnostics. (3)  “Payment” means the transfer by a blood bank, or any other party, to any person of money or any other valuable consideration which can be converted to money by the recipient, except that “payment” shall not include any of the following: (i)  Cancellation or refund of the nonreplacement fees or related blood transfusion charges. (ii)  Blood assurance benefits to a person as a result of a blood donation to a donor club or blood assurance program. (iii)  Time away from employment granted by an employer to an employee in order to donate blood. (c)  Any blood bank receiving blood from a blood bank outside of California shall comply with the labeling requirements of this chapter. Any blood bank receiving this blood may label the blood as “volunteer donor” blood only if the blood bank receives with the blood a certificate from the out-of-state blood bank which states either that the particular shipment of blood was acquired from volunteer donors not receiving payment or that all blood processed by the out-of-state blood bank is acquired from volunteer donors not receiving payment. If the blood bank receiving such blood receives no such certificate with the blood, the blood shall be labeled as “paid donor” blood. (d)  No warranty shall be implied from the fact that any blood is labeled in accordance with the requirements of this section. (Amended by Stats. 1989, Ch. 513, Sec. 1.)
CA Health & Safety Code § 1604 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 2 - Human Whole Blood and Human Whole Blood Derivatives|Section 1604.

1604.  The distribution or release for distribution by blood banks of human whole blood, or those human whole blood derivatives specified by regulation, shall be made only to blood bank depositories or to other licensed blood banks.(Repealed and added by Stats. 1963, Ch. 1055.)
CA Health & Safety Code § 1604.6 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 2 - Human Whole Blood and Human Whole Blood Derivatives|Section 1604.6.

1604.6.  (a) Notwithstanding any other provision of law, in order to provide umbilical cord blood banking storage services, a blood bank shall be licensed pursuant to this chapter. Any additional standards for blood banks to store umbilical cord blood may be implemented by the department through the adoption of regulations.(b) (1) The department may adopt emergency regulations to implement and make specific subdivision (a) in accordance with Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. For purposes of the Administrative Procedure Act, the adoption of regulations shall be deemed an emergency and necessary for the immediate preservation of the public peace, health and safety, or general welfare.(2) (A) Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, these emergency regulations shall not be subject to the review and approval of the Office of Administrative Law. Notwithstanding Sections 11346.1 and 11349.6 of the Government Code, the department shall submit these regulations directly to the Secretary of State for filing.(B) Emergency regulations adopted pursuant to this section shall become effective immediately upon filing by the Secretary of State, shall be subject to public hearing within 120 days of filing with the Secretary of State, and shall comply with Sections 11346.8 and 11346.9 of the Government Code, or shall be repealed by the department.(3) The Office of Administrative Law shall provide for the printing and publication of emergency regulations adopted pursuant to this section in the California Code of Regulations.(4) Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, and subject to subparagraph (B) of paragraph (2), the emergency regulations adopted pursuant to this subdivision shall not be repealed by the Office of Administrative Law and shall remain in effect until revised or repealed by the department.(Amended by Stats. 2007, Ch. 130, Sec. 160. Effective January 1, 2008.)
CA Health & Safety Code § 1605 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 2 - Human Whole Blood and Human Whole Blood Derivatives|Section 1605.

1605.  Establishments which receive human whole blood and human whole blood derivatives specified by regulation and are not subject to license in accordance with this chapter shall be considered as blood bank depositories. Laboratory tests and other procedures with respect to the preparation of blood for transfusion shall be the sole responsibility of the blood bank depository.(Repealed and added by Stats. 1963, Ch. 1055.)
CA Health & Safety Code § 1606 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 2 - Human Whole Blood and Human Whole Blood Derivatives|Section 1606.

1606.  The procurement, processing, distribution, or use of whole blood, plasma, blood products, and blood derivatives for the purpose of injecting or transfusing the same, or any of them, into the human body shall be construed to be, and is declared to be, for all purposes whatsoever, the rendition of a service by each and every person, firm, or corporation participating therein, and shall not be construed to be, and is declared not to be, a sale of such whole blood, plasma, blood products, or blood derivatives, for any purpose or purposes whatsoever.(Repealed and added by Stats. 1963, Ch. 1055.)
CA Health & Safety Code § 1607.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 2 - Human Whole Blood and Human Whole Blood Derivatives|Section 1607.5.

1607.5.  (a)  Notwithstanding any other provision of law, a person who has attained the age of 17 may consent to the donation of his or her blood and to the penetration of tissue which is necessary to accomplish such donation, and a blood bank may accept such donation. (b)  Notwithstanding any other provision of law, a person who has attained the age of 15 may consent to the donation of his or her blood and to the penetration of tissue which is necessary to accomplish such donation, and a blood bank may accept such donation, if he or she has the written consent of his or her parents or a guardian, and the written authorization of a physician and surgeon. (c)  As used in this section “donation of blood” means a giving of blood in which the donor of the blood receives no payment therefor. (Amended by Stats. 1981, Ch. 23.)
CA Health & Safety Code § 1608 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 2 - Human Whole Blood and Human Whole Blood Derivatives|Section 1608.

1608.  This chapter does not repeal or in any manner affect any provision of the Business and Professions Code relating to the practice of medicine.(Repealed and added by Stats. 1963, Ch. 1055.)
CA Health & Safety Code § 1609 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 3 - Biologics Other Than Human Whole Blood and Human Whole Blood Derivatives|Section 1609.

1609.  No person shall engage in the production of biologics other than human whole blood and human whole blood derivatives unless:(a)  In a laboratory licensed by the Public Health Service, United States Department of Health, Education and Welfare. (b)  In a laboratory licensed by the Animal Inspection and Quarantine Branch, Agricultural Research Service, United States Department of Agriculture. (c)  Under the provisions of this chapter. (Repealed and added by Stats. 1963, Ch. 1055.)
CA Health & Safety Code § 1610 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 3 - Biologics Other Than Human Whole Blood and Human Whole Blood Derivatives|Section 1610.

1610.  The department shall make rules and regulations governing the production of all biologics produced in establishments under subdivision (c) of Section 1609.(Repealed and added by Stats. 1963, Ch. 1055.)
CA Health & Safety Code § 1611 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 3 - Biologics Other Than Human Whole Blood and Human Whole Blood Derivatives|Section 1611.

1611.  The department may make rules and regulations governing the transportation or distribution of cultures of micro-organisms which may produce disease in man or animals.(Repealed and added by Stats. 1963, Ch. 1055.)
CA Health & Safety Code § 1613 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 4 - Licenses|Section 1613.

1613.  Applications for licenses issued under this chapter shall be made upon forms issued by the department. The applications shall contain at least the following:(a)  The name and address of the person owning the place, establishment, or institution in which biologics production is planned. (b)  The name and address of the person to be in charge of biologics production. (c)  The types of biologics to be produced. (d)  A full description of the building, its location, facilities, equipment, and apparatus to be used in biologics production. (e)  The name and address of each blood collection center operated by the applicant and whether the applicant operates any mobile units. (f)  Any additional information as the department may require. (Amended by Stats. 1991, Ch. 800, Sec. 12.)
CA Health & Safety Code § 1614 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 4 - Licenses|Section 1614.

1614.  If the department does not within 60 days after the filing of the application issue a license, it shall state the grounds and reasons for its refusal in writing, serving a copy upon the applicant.The notice may be served by registered mail addressed to the applicant at his last known address.(Amended by Stats. 1991, Ch. 800, Sec. 13.)
CA Health & Safety Code § 1615 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 4 - Licenses|Section 1615.

1615.  (a)  A license shall be automatically revoked when there is a change of address, ownership, or person in charge of biologics production. However, a new license may be secured for the new location, owner, or person in charge prior to the actual change if the contemplated change is in compliance with all the provisions of this chapter and regulations pertaining thereto. (b)  Proceedings for denial of license shall be conducted in accordance with Section 100171. (Amended by Stats. 1997, Ch. 220, Sec. 18. Effective August 4, 1997.)
CA Health & Safety Code § 1616 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 5 - Revenue|Section 1616.

1616.  (a)  Each application for a license or license renewal under this chapter shall be accompanied by a fee determined by the director by regulations and in an amount sufficient to cover the cost of administering this chapter but not to exceed those costs, as specified pursuant to Section 1616.5. (b)  The state department shall receive and account for all moneys received pursuant to this chapter and shall deposit them with the Treasurer for deposit in the Clinical Laboratory Improvement Fund established pursuant to Section 1302 of the Business and Professions Code. All funds received pursuant to this chapter shall, upon appropriation, be expended to administer this chapter. (c)  Each license issued under this chapter shall expire 12 months from the date of its issuance. Application for renewal of license accompanied by the fee shall be filed with the department not less than 10 days prior to the expiration each year. Failure to make a timely renewal shall result in expiration of the license. (Amended by Stats. 1994, Ch. 492, Sec. 5. Effective January 1, 1995.)
CA Health & Safety Code § 1616.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 5 - Revenue|Section 1616.5.

1616.5.  (a)  The fee required pursuant to Section 1616 for the calendar year commencing January 1, 1992, and for each fiscal year thereafter unless adjusted pursuant to subdivision (b), shall not exceed the following: One thousand five hundred dollars ($1,500) for a blood bank and no more than one blood collection center operated at the same location as the blood bank. In addition and irrespective of the location of the blood collection center, a fee of five hundred dollars ($500) for each additional blood collection center operated by the blood bank up to a maximum of one thousand five hundred dollars ($1,500) for three or more blood collection centers.(b)  The maximum application and renewal fees for blood bank licenses pursuant to subdivision (a) shall be adjusted annually in the manner specified in Section 100450. The adjustments shall be rounded off to the nearest whole dollar. (c)  This chapter shall not be interpreted to exempt the state, a district, city, county, or city and county, from payment of fees or from meeting the requirements established pursuant to this chapter or regulations adopted thereunder. (Amended by Stats. 1996, Ch. 1023, Sec. 169. Effective September 29, 1996.)
CA Health & Safety Code § 1617 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 6 - Enforcement|Section 1617.

1617.  (a)  The department shall administer this chapter. (b)  In order to carry out this chapter, any duly authorized representative of the department may do any of the following: (1)  Enter or inspect on an announced or unannounced basis any building, premise, equipment, materials, records, or information at any reasonable time to secure compliance with, or prevent a violation of, this chapter or the regulations adopted pursuant thereto. (2)  Inspect, photograph, or copy any records, reports, test results, test specimens, or other information related to the requirements of this chapter or the regulations adopted pursuant thereto. (3)  Secure any sample, photograph, or other evidence from any building or premise for the purpose of enforcing this chapter or the regulations adopted pursuant thereto. (Amended by Stats. 1991, Ch. 800, Sec. 16.)
CA Health & Safety Code § 1618 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 6 - Enforcement|Section 1618.

1618.  (a)  Licenses shall be suspended or revoked by the department for the violation of any provision of this chapter, or of any rule or regulation made by the department under authority conferred by this chapter. The proceedings shall be conducted in accordance with Section 100171. (b)  Licenses may be denied for any reason applicable to revocation and suspension of licenses. (c)  District and city attorneys shall prosecute violations of this chapter upon evidence of violations within their respective jurisdictions submitted by the department. (Amended by Stats. 1997, Ch. 220, Sec. 19. Effective August 4, 1997.)
CA Health & Safety Code § 1619 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 6 - Enforcement|Section 1619.

1619.  Nothing in this chapter shall be considered to be in conflict with Part 5 (commencing with Section 109875) of Division 104 of this code and all provisions of that division shall apply to biologics within the meaning of this chapter, except that this chapter shall not apply to products of:(a)  A laboratory licensed by the Public Health Service, United States Department of Health, Education and Welfare. (b)  A laboratory licensed by the Animal Inspection and Quarantine Branch, Agricultural Research Service, United States Department of Agriculture. (Amended by Stats. 1996, Ch. 1023, Sec. 170. Effective September 29, 1996.)
CA Health & Safety Code § 1620 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 6 - Enforcement|Section 1620.

1620.  The violation of any provision of this chapter is a misdemeanor punishable by a fine of not less than one hundred dollars ($100) nor more than one thousand dollars ($1,000), or by imprisonment for not more than 30 days, or by both.(Amended by Stats. 1983, Ch. 1092, Sec. 148. Effective September 27, 1983. Operative January 1, 1984, by Sec. 427 of Ch. 1092.)
CA Health & Safety Code § 1625 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 7 - Blood Donations|Section 1625.

1625.  As used in this article:(a)  “Blood” means human whole blood or components of human blood, including plasma, which are prepared from human whole blood by physical, rather than chemical processes, but does not include blood derivatives manufactured or processed for industrial use. (b)  “Cytapheresis” means the separation and collection of blood cells by hemapheresis. (c)  “Hemapheresis” means the removal of whole blood from a donor, separation of the blood into components, retention of the desired components, and return of the recombined remaining elements to the donor. (d)  “Industrial use” means a use of blood in which the blood is modified by physical or chemical means to produce derivatives for therapeutic or pharmaceutic biologics, laboratory reagents, or in vitro diagnostics. (e)  “Paid donor” means a person who donates blood and who receives payment in return for the donation of such blood. (f)  “Payment” means the transfer by a blood bank to any person of money or any other valuable consideration which can be converted to money by the recipient, except that payment shall not include any of the following: (1)  Cancellation or refund of the nonreplacement fees or related blood transfusion charges. (2)  Blood assurance benefits to a person as a result of a blood donation to a donor club or blood assurance program. (3)  Time away from employment, with or without pay, granted by an employer to an employee in order to donate blood. (g)  “Person” means any individual, blood bank, hospital, firm, corporation, or any other entity. (h)  “Transfusion” means a use of blood in which the blood is administered to a human being for treatment of sickness or injury. (Amended by Stats. 1986, Ch. 1007, Sec. 2.)
CA Health & Safety Code § 1625.1 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 2 - LICENSING PROVISIONS|CHAPTER 4 - Human Whole Blood, Human Whole Blood Derivatives, and Other Biologics|ARTICLE 7 - Blood Donations|Section 1625.1.

1625.1.  In addition to the requirements of Section 1602.1, subdivisions (a) to (c), inclusive, of Section 1002 of Title 17 of the California Administrative Code, and any other requirements identified by the State Department of Health Services, hemapheresis donors shall provide a medical history questionnaire completed by a trained interviewer who questions and verifies the accuracy of responses before every donation.The department may require testing or examinations to reflect changing technology and to increase the safety of blood products.(Added by Stats. 1986, Ch. 1007, Sec. 3.)